Placebo-subtracted mean weight loss up to 14.1% after 28 weeks with no plateau Potential for best-in-class tolerability with minimal diarrhea signal, 13% nausea, and 11% vomiting High study and ...

Pfizer enters the obesity drug market with its Metsera acquisition, aiming to challenge leaders Eli Lilly and Novo Nordisk.

Great. Thanks for joining us, everyone. I'm Terence Flynn, the U.S. biopharma analyst here at Morgan Stanley. I'm very pleased to be hosting Structure Therapeutics. Joining us today from the company, ...

In The Lancet Diabetes & Endocrinology, the STEP-UP T2D and STEP-UP trial groups present new findings on the efficacy and safety of higher-dose semaglutide (7·2 mg once weekly) in individuals with ...

Of all the possible side effects that come with taking a GLP-1, losing your hair is perhaps one of the scariest. The good ...

WeDosify becomes CLM’s first commercially available product – delivering data-driven, adaptive dosing recommendations to improve GLP-1 adherence.Informed by 29 studies and 15,000+ patient profiles; ...

A technical advance in search of its clinical place Insulin remains a cornerstone of treatment for many people with type 2 diabetes whose blood glucose levels are not adequately controlled with oral ...

The 2018 Lancet Commission,1 After asthma: redefining airways diseases, made clear recommendations to improve outcomes for ...

Working together as a team to better communicate between physicians and nurses as well as the complete caregiving team will ...

Statistically significant responder rate achieved at 12 weeks with zero contribution from rescue therapy (PRN) and further improvement sustained ...

By seeing yourself with grace, you create an internal safe space where you can grow. You can love your shadow and feel unconditional love, When you have your own back, you’ll feel braver to take the ...

That’s a solid price for what one reviewer says has been a “total game changer for my energy and focus.” (According to multiple previous HuffPost reports, there is indeed a correlation between walking ...